1. Early diagnosis of cardiotoxic complications of chemotherapy: the possibility of radiation research methods
- Author
-
E. V. Goncharova and M. V. Chistyakova
- Subjects
medicine.medical_specialty ,Cardiotoxicity ,Chemotherapy ,Myocardial ischemia ,business.industry ,medicine.medical_treatment ,Cancer ,medicine.disease ,Tumor Process ,Heart failure ,medicine ,Risk of death ,Cardiology and Cardiovascular Medicine ,Intensive care medicine ,business ,Cardiovascular mortality - Abstract
Oncological diseases are the main causes of death in the world. Modern treatment of cancer patients contributes to an increase in survival rate due to strong chemotherapeutic drugs, the use of which is accompanied by toxic effects on cardiomyocytes. The main manifestations of cardiotoxicity are left ventricular dysfunction, myocardial ischemia, thromboembolic complications, chronic heart failure. As a result, the risk of cardiovascular mortality may be higher than the risk of death from the tumor process. An important task of oncologists and cardiologists is the early diagnosis of cardiotoxic complications in order to start treatment in time and reduce mortality from cardiovascular pathology in cancer patients.
- Published
- 2018
- Full Text
- View/download PDF